Latest On Sino Biopharmaceutical Limited (SBMFF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-10-05 05:58 EST | Dividend | A dividend of $0.02 has been announced on Aug 25, 2023. It will be paid Oct 27, 2023 with an ex-dividend date of Oct 5, 2023. | Neutral |  |
| 2023-06-22 05:58 EST | Dividend | A dividend of $0.06 has been announced on Mar 31, 2023. It will be paid Jul 17, 2023 with an ex-dividend date of Jun 22, 2023. | Neutral | |
| 2022-09-07 05:58 EST | Dividend | A dividend of $0.06 has been announced on Aug 23, 2022. It will be paid Sep 28, 2022 with an ex-dividend date of Sep 7, 2022. | Neutral | |
| 2022-06-16 05:58 EST | Dividend | A dividend of $0.04 has been announced on Mar 31, 2022. It will be paid Jul 12, 2022 with an ex-dividend date of Jun 16, 2022. | Neutral | |
| 2021-06-21 06:01 EST | Dividend | A dividend of $0.02 has been announced on Mar 23, 2021. It will be paid Jul 12, 2021 with an ex-dividend date of Jun 21, 2021. | Neutral | |
| 2020-12-14 05:02 EST | Dividend | A dividend of $0.02 has been announced on Nov 30, 2020. It will be paid Dec 31, 2020 with an ex-dividend date of Dec 14, 2020. | Neutral | |
| 2020-12-13 01:10 EST | News | Sino Biopharmaceutical: Investing In China's COVID-19 Vaccine While Sinovac Remains Halted | N/A | |
| 2020-12-02 21:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 22:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-25 22:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-15 05:59 EST | Dividend | A dividend of $0.02 has been announced on Aug 28, 2020. It will be paid Sep 30, 2020 with an ex-dividend date of Sep 15, 2020. | Neutral | |
| 2020-08-29 22:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-15 05:59 EST | Dividend | A dividend of $0.02 has been announced on Mar 30, 2020. It will be paid Jul 6, 2020 with an ex-dividend date of Jun 15, 2020. | Neutral | |
| 2020-06-14 06:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 18:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-10 02:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 22:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 22:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 05:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 23:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 01:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 00:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 01:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-10 11:33 EST | Stock Split | A stock split has occured on Jun 4, 2018 with a split factor of 3:2. | Neutral | |
About Sino Biopharmaceutical Limited (SBMFF):
Sino Biopharmaceutical Limited, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. The company operates in three segments: Chinese Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; oncology medicines comprising Saiweijian injections, Yinishu tablets, Shoufu tablets, Anxian capsules, and Qianping injections; cardio-cerebral medicines, including Yilunping tablets, Tuotuo tablets, and Kaina tablets; and orthopedic medicines, such as Gaisanchun capsules and Yigu injections. The company's principal products also comprise digestive system medicines that consist of Aisuping injections, Getai tablets, and Deyou granules; anti-infectious medicines that include Tiance injections, Tianjie injections, and Tianli injections; respiratory system medicines, such as Tianqingsule inhalation powder; and others comprising Debaian cataplasms. In addition, it engages in property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management consultancy services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
General
- Name Sino Biopharmaceutical Limited
- Symbol SBMFF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 24,328
- Last Split Factor3:2
- Last Split Date2020-07-20
- Fiscal Year EndDecember
- Web URLhttp://www.sinobiopharm.com
Valuation
- Trailing PE 34.24
- Forward PE 45.45
- Price/Sales (Trailing 12 Mt.) 5.22
- Price/Book (Most Recent Quarter) 4.05
- Enterprise Value Revenue 0.81
- Enterprise Value EBITDA 3.38
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin 10%
- Return on Assets 4%
- Return on Equity 10%
- Earnings Per Share $0.03
- Revenue Per Share $0
- Gross Profit 19.31 billion
- Quarterly Earnings Growth -19.4%
ESG Rating
Highlights
- Market Capitalization 21.76 billion
- PEG Ratio 11.64
- Book Value Per Share $0.25
Share Statistics
- Shares Outstanding 18.86 billion
- Shares Float 8.9 billion
- % Held by Insiders 4749%
- % Held by Institutions 15.9%
Technicals
- Beta 0.56
- 52 Week High $1.45
- 52 Week Low $0.79
- 50 Day Moving Average 1.03
- 200 Day Moving Average 1.02
Dividends
- Forward Annual Dividend Rate $0.01
- Forward Annual Dividend Yield 0.91%
- Payout Ratio 18%
- Dividend Date 2017-12-15
- ExDividend Date 2020-12-11
- Dividend Per Share $0.01
- Dividend Yield 0%
Sino Biopharmaceutical Limited (SBMFF) Dividend Calendar:
SBMFF's last dividend payment was made to shareholders on December 15, 2017.
Sino Biopharmaceutical Limited pays out 18% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Sino Biopharmaceutical Limited (SBMFF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-30 | $N/A | $0.03 | $0.05 | -40% |
| 2020-06-30 | 2020-09-30 | $N/A | $0.01 | $0.04 | -87.5% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.00 | $0.04 | -93.5% |
| 2019-12-31 | 2020-03-31 | $N/A | $0.01 | $0.05 | -87.2% |
| 2019-09-30 | 2019-12-31 | $6.79 billion | $0.00 | $0.04 | -91.25% |
| 2019-06-30 | 2019-09-30 | $6.32 billion | $0.01 | $0.04 | -85% |
| 2019-03-31 | 2019-06-30 | $6.21 billion | $0.00 | $0.05 | -91% |
| 2018-12-31 | 2019-03-31 | $5.16 billion | $0.01 | $0.04 | -83% |
| 2018-09-30 | 2018-12-31 | $6 billion | $0.05 | $0.05 | 8.4% |
| 2018-06-30 | 2018-09-30 | $3.85 billion | $0.01 | $0.04 | -84% |
| 2018-03-31 | 2018-06-30 | $4.65 billion | $0.00 | $0.07 | -93.29% |
| 2017-12-31 | 2018-03-31 | $3.37 billion | $0.01 | $0.04 | -83% |
| 2017-09-30 | 2017-12-31 | $4.65 billion | $0.00 | $0.05 | -92.2% |
| 2017-06-30 | 2017-09-30 | $3.62 billion | $0.01 | $0.04 | -84.75% |
| 2017-03-31 | 2017-06-30 | $3.86 billion | $0.00 | $0.05 | -91.6% |
| 2016-12-31 | 2017-03-31 | $3.5 billion | $0.01 | $0.04 | -87.5% |
| 2016-09-30 | 2016-12-31 | $0.00 | $0.04 | -94.75% | |
| 2016-06-30 | 2016-09-30 | $0.00 | $0.03 | -86% | |
| 2016-03-31 | 2016-06-30 | $0.00 | $0.06 | -93.33% | |
| 2015-12-31 | 2016-03-31 | $0.00 | $0.05 | -92% | |
| 2015-09-30 | 2015-12-31 | $0.00 | $0.07 | -95.71% | |
| 2015-06-30 | 2015-09-30 | $0.00 | $0.05 | -92.8% | |
| 2015-03-31 | 2015-06-30 | $0.00 | |||
| 2014-12-31 | 2015-03-31 | $0.00 | $0.04 | -92.25% | |
| 2014-09-30 | 2014-12-31 | $0.00 | $0.06 | -95.33% | |
| 2014-06-30 | 2014-09-30 | $0.00 | $0.04 | -89.75% | |
| 2014-03-31 | 2014-06-30 | $0.00 | |||
| 2013-12-31 | 2014-03-31 | $0.00 | |||
| 2013-09-30 | 2013-12-31 | $0.00 | |||
| 2013-06-30 | 2013-09-30 | $0.00 | |||
| 2013-03-31 | 2013-06-30 | $0.00 | |||
| 2012-12-31 | 2013-03-31 | $0.00 | |||
| 2012-09-30 | 2012-12-31 | $0.00 | |||
| 2012-06-30 | 2012-09-30 | $0.00 | |||
| 2012-03-31 | 2012-06-30 | $0.00 | |||
| 2011-12-31 | 2012-03-31 | $0.00 | |||
| 2011-09-30 | 2011-12-31 | $0.00 | |||
| 2011-06-30 | 2011-09-30 | $0.00 | |||
| 2011-03-31 | 2011-06-30 | $0.00 | |||
| 2010-12-31 | 2011-03-31 | $0.00 | |||
| 2010-09-30 | 2010-12-31 | $0.00 | |||
| 2010-06-30 | 2010-06-30 | $0.00 | |||
| 2010-03-31 | 2010-03-31 | $0.00 |
Sino Biopharmaceutical Limited (SBMFF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Sino Biopharmaceutical Limited (SBMFF) Chart:
Sino Biopharmaceutical Limited (SBMFF) News:
Below you will find a list of latest news for Sino Biopharmaceutical Limited (SBMFF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sino Biopharmaceutical Limited (SBMFF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Sino Biopharmaceutical Limited (SBMFF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-01-24 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000101915520000020/0001019155-20-000020-index.htm |
| 2014-04-08 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380514000751/0001193805-14-000751-index.htm |
| 2016-05-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380516003321/0001193805-16-003321-index.htm |
| 2016-09-13 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380516003943/0001193805-16-003943-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1604982/000119380517002605/0001193805-17-002605-index.htm |
| 2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380519001656/0001193805-19-001656-index.htm |